Viatris recalls Candesartan Cilexetil Tablets, USP 16 mg, 30 count bottles, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, W…
- Recall date
- September 13, 2021
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-0798-2021
- FDA classification
- Class III
- Brand / firm
- Viatris
- Sold / distributed
- Product was distributed nationwide.
Why it was recalled
Failed Impurities/Degradation Specifications; out of specification for Related Compound
Class III means the product violates regulations but is not likely to cause harm.
What was recalled
Candesartan Cilexetil Tablets, USP 16 mg, 30 count bottles, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 NDC 0378-3231-93
Get recall alerts
Free email alert whenever Viatris has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Viatris